34 results about "Aggregation rate" patented technology

A photocurable composition of the present invention to be used for manufacturing a film with high productivity is a photocurable composition to be used for manufacturing a film having a predetermined pattern shape by curing the photocurable composition with light under a state where the photocurable composition is brought into contact with a mold having concavo-convex on a surface thereof, the photocurable composition including: a polymerizable compound; a photopolymerization initiator; a photosensitive gas generating agent for generating a gas through light stimulation; and a gas generation promotor for increasing an aggregation rate of the gas generated from the photosensitive gas generating agent at an interface between the mold and the photocurable composition, in which the gas generation promotor includes a fluorine atom-containing surfactant that is free of a polymerizable substituent.

A method for calibrating machines suitable to effect an analysis of a blood sample by means of measuring the erythrocyte sedimentation rate (ESR) and / or aggregation of the red corpuscles, wherein said measurement is effected by exploiting the optical density kinetics obtained from the measurement of the variation in the optical density of the blood sample in an interval of time, comprises a measuring step in which, by means of the same machine with which the measurement of the optical density is effected on said blood sample, a measurement is effected of the optical density of two latexes, or turbidimetric samples. Each of the two latexes has a known optical density, reproducible, measurable and different from each other. The method also comprises a comparison step, in which the difference is calculated between the values of optical density of the latexes as obtained from the measurement performed by the machine and the known values of optical density, to allow to determine at least one correction factor usable to calibrate said machine.

The invention discloses a method for loading an appearance-controllable bi-metal nano-composite material between a two-dimensional laminar material and a conductive polymer double carrier. The method comprises the following steps: step I, adding a bi-metal salt-containing solution into a two-dimensional laminar material-containing solution, so as to form a uniform solution; step II, adding conductive polymer monomer into the solution obtained in the step I; step III, removing unreacted monomer from the solution obtained in the step II, and washing with deionized water, so as to obtain the bi-metal nano-composite material. The method has the advantages that not only are the synthesis steps simple, but also the catalyst stability is high, separation for recycling is convenient, the service life of a catalyst is greatly prolonged, and the problems of high aggregation rate, short service life and low cyclic utilization efficiency of the conventional metal nano-catalyst in practical application are solved. More importantly, due to simple experiment parameter regulation, the appearance of the bi-metal nano-composite material can be controlled effectively, and the catalytic activity of the catalyst is further improved. Therefore, the purpose of using the catalyst efficiently is realized.

An optimized platelet aggregation function detection analysis method suitable for automated instrument belongs to the field of clinical laboratory medicine. The method is an improvement and optimization of an automatic counting detection method for detection analysis of platelet aggregation function. The process is applicable to platelet aggregation function automated analytical instrument employing a counting method. The method detects and records the amount of platelet and calculates aggregation rate. Test results by the laboratory show that the repeatability of the platelet aggregation rate result obtained by the method is superior to that of a prior maximum aggregation rate method.

The invention provides a method for preparing a single crystal or amorphous substance of a medicine or a medicine intermediate with adjustable particle size. According to the method, the supply and aggregation rate of medicine or medicine intermediate molecules is controlled by freezing and curing a medicine or medicine intermediate solution, so that the medicine or medicine intermediate single crystal or amorphous substance with adjustable particle size is prepared. Controllable preparation of the single crystal or amorphous substance of the medicine or the medicine intermediate is achieved in a mode of freezing the medicine or the medicine intermediate solution for the first time; by controlling the freezing and curing process of the solution, the supply rate and aggregation rate of themedicine or medicine intermediate are regulated and controlled, so that whether the medicine or medicine intermediate can be nucleated and crystallized and the crystal growth condition thereof are regulated and controlled, and the single crystal or amorphous substance of the medicine or medicine intermediate is efficiently prepared. Meanwhile, the particle size of the medicine or the medicine intermediate single crystal or amorphous substance is regulated and controlled by controlling the curing temperature.

The invention discloses a method for purifying dodecanedioic acid, which comprises the following steps of: carrying out demulsification, filtration and decoloration on stop fermentation liquor of dibasic acid and adding pure water to dilute; adding purified water into a crystallization kettle, pumping diluted fermented clear liquid into a crystallizer, simultaneously filling dilute sulphuric acid with the mass concentration of 30 percent into a discharge hole of an external circulating pump and adding the dilute sulphuric acid into the crystallizer, and controlling the PH of reaction materials; ensuring crystal mush to flow to the lower part of a crystallization chamber through a central downcomer and then flow upwards, so that crystals with large granularities are enriched on the bottom layer of the crystallization chamber; and cooling the crystals outflowing from a discharge hole of the crystallizer by a cooler and carrying out filter pressing, washing and drying to obtain the dodecanedioic acid. Due to the adoption of the purifying method, the micro mixing effect is achieved by diluting local concentration of the reaction mass through the material circulating pump, the solution nucleation rate, the crystal growth rate and the aggregation rate are reduced, the moisture percentage and the impurity content of a filter cake are obviously reduced, the dried dibasic acid product has large and uniform particles, good glossy and high purify, and the continuity of the crystallizing process is realized.

The invention discloses a preparation method of a silicone styrene-acrylic microemulsion, which comprises mixing styrene, an acrylic ester monomer, a silicone monomer and a stabilizer, and stirring until completely dissolved to obtain an oil phase mixture; mixing the emulsifier Dissolved with water, stirred evenly to obtain a water phase mixture; organosilicon monomers include non-functional organosilicon monomers and functional organosilicon monomers, wherein the non-functional organosilicon monomers are methyltrimethyl(ethyl)oxy At least one of silane, propyltrimethyl(ethyl)oxysilane or phenyltrimethyl(ethyl)oxysilane; the oil phase mixture is added to the water phase mixture, and after hydrolysis-emulsification reaction, ultrafine emulsification is carried out, The mixed solution is subjected to mini-emulsion polymerization under an oxygen-free condition of 60-100°C to obtain a silicone styrene-acrylic emulsion. Both the silicon content and the solid content of the organosilicon styrene-acrylic miniemulsion prepared by the invention are relatively high, and the aggregation rate can be reduced to less than 1%.

The invention discloses a method for detecting the activity of alpha7nAChR of blood platelets and application of alpha7nAChR. The Ca2+ internal flow of a blood platelet alpha7nAChR positive ion channel is detected, and the adhesion and aggregation effects of alpha7nAChR on blood platelets are detected. Compared with alpha7nAChR in a non-activated state, selectively-activated alpha7nAChR can cause increase of the Ca2+ internal flow of blood platelets and induce increase of the adhesion rate and aggregation rate of blood platelets, and thus the activity of alpha7nAChR of blood platelets can be evaluated.

The invention provides a method for detecting activity of NMDA (N-methyl-D-aspartate) receptors of blood platelets and an application of the method. The activity of the NMDA receptors of the blood platelets is reflected through regulation of Ca<2+> influx of NMDA receptor channels of the blood platelets and detection for an acceleration function of the NMDA receptors on blood platelet adhesion and aggregation. The method comprises specific steps as follows: (1), the blood platelets are processed by a selective NMDA receptor stimulant NMDA, glutamate or glycine, and the NMDA receptors are activated, so that the Ca<2+> influx of the blood platelets can be increased and the adhesion rate and the aggregation rate of the blood platelets can be increased; (2), the blood platelets are processed by a selective NMDA receptor antagonist and memantine, and the NMDA receptors are blocked, thus, the Ca<2+> influx of the blood platelets can be decreased and the adhesion rate and the aggregation rate of the blood platelets can be decreased; therefore, the activity of the NMDA receptors of the blood platelets is reflected.

The present invention provides a method for configuring the aggregated maximum rate of the UE, including: A. the master base station MeNB obtains the aggregated maximum rate UE-AMBR of the UE; B. the master base station MeNB obtains information for configuring the aggregated maximum rate of the slave base station SeNB , and configure the aggregated maximum rate used by the SeNB according to the information. The present application also provides a method for coordinating the aggregation rate of non-GBR services among base stations, and a base station corresponding to the above two methods. By applying this application, when non-GBR services are established in different base stations, the maximum value of the aggregation rate used by each base station can be allocated, and the limited bearer bandwidth can be effectively used to reduce data transmission delay.